Rhythm Pharmaceuticals gains on report of additional bidder
Seeking Alpha ·
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.
1 sources · 1 articles · updated 2026-11-06 16:06 UTC · business
Seeking Alpha ·
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.